JPMorgan's October stock list combines several different investment themes rather than one broad market call.
The supplied source highlights American Express, Liberty Energy and Thermo Fisher Scientific among names added to the bank's preferred ideas.
American Express represents the value case. Shares were down about 18% year to date at the time of the report as investors worried about consumer resilience and credit conditions.
JPMorgan analyst Richard Shane argued that American Express remains attractive because of its high returns and disciplined capital return, including dividends and share repurchases.
Liberty Energy represents a different theme: electricity demand created by AI infrastructure.
The stock had risen more than 50% over the prior year, but JPMorgan still saw upside from a structurally tight behind-the-meter power market. The bank expects data-center load growth to support demand for distributed generation through the end of the decade.
Thermo Fisher Scientific adds a life-sciences angle. The shares had advanced more than 25% over three months, supported by the company's financial outlook and an early-disease-detection partnership with Mayo Clinic.
JPMorgan also linked the opportunity to broader AI adoption and U.S. biopharma reshoring.
For investors, the list shows how major themes are spreading beyond the obvious mega-cap AI stocks. Power generation, financial services and life-sciences tools can all benefit from different parts of the current economic cycle.
The main risk is that each thesis depends on a different macro variable. American Express is sensitive to consumer health and credit; Liberty Energy to energy and power investment; Thermo Fisher to biopharma spending and execution.
What investors should watch: American Express credit trends and buybacks, Liberty Energy's distributed-power demand, Thermo Fisher's growth outlook, estimate revisions and whether the themes continue to outperform broader market benchmarks.
BTI's bottom line: JPMorgan's October list is useful less as a group trade than as a map of where analysts see differentiated opportunities. The strongest ideas are tied to distinct earnings drivers rather than simply broad market momentum.